COMET: Ductal Carcinoma in SITU - Clinical Trial
Email to Participate
cindy.downing@duke.edu
What is the Purpose of this Study?
If you choose to join this study, you will:
- Be randomized (like a flip of a coin) into one of two treatment groups:
--- Group 1 will get traditional treatment with radiation, surgery, and chemotherapy
--- Group 2 will have close monitoring of their disease with possible chemotherapy
- Have tests, exams, and procedures that are part of your standard of care and for study purposes
What is the Condition Being Studied?
Ductal Carcinoma in Situ (DCIS)
Who Can Participate in the Study?
Adult women over age 40 who:
- Have a new diagnosis of DCIS without invasive cancer
- Have no prior history of breast cancer in either breast
Age Group
Adults
What is Involved?
We are doing this study to compare the risks and benefits of the usual treatment approach for DCIS with a close disease-monitoring approach.
Study Details
Full Title
COMPARISON OF OPERATIVE TO MONITORING AND ENDOCRINE THERAPY (COMET) TRIAL FOR LOW RISK DCIS: A PHASE III PROSPECTIVE RANDOMIZED TRIAL
Principal Investigator
Surgical Oncologist
Protocol Number
IRB:
PRO00080888
NCT:
NCT02926911
Phase
Phase
III
ClinicalTrials.gov
View on ClinicalTrials.gov
Enrollment Status
Open for Enrollment
Participate
Email cindy.downing@duke.edu